Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3
Translational and Clinical Outcomes
Herausgeber: Nagaraju, Ganji Purnachandra; Ahmad, Sarfraz
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3
Translational and Clinical Outcomes
Herausgeber: Nagaraju, Ganji Purnachandra; Ahmad, Sarfraz
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Description based on volume 2, published 2022.
Andere Kunden interessierten sich auch für
- Said Abbas (Professor, Department of Mathematics, Tahar Moulay UnivFractional Difference, Differential Equations, and Inclusions184,99 €
- Paul Harmon (Enterprise Alignment, San Francisco, CA, USA)Business Process Change84,99 €
- Michael S. LubellNavigating the Maze49,99 €
- Javier TarangoThe Role of Information Professionals in the Knowledge Economy54,99 €
- Suzanne Wilson-HigginsThe Impact of Print-On-Demand on Academic Books54,99 €
- Miguel EscobarMaster Your Data with Power Query in Excel and Power Bi: Leveraging Power Query to Get & Transform Your Task Flow29,99 €
- Almudena Sánchez VillegasThe Prevention of Cardiovascular Disease Through the Mediterranean Diet69,99 €
-
-
-
Produktdetails
- Produktdetails
- Verlag: Elsevier Science & Technology
- Seitenzahl: 468
- Erscheinungstermin: 21. April 2022
- Englisch
- Abmessung: 235mm x 191mm
- Gewicht: 1124g
- ISBN-13: 9780323992831
- ISBN-10: 0323992838
- Artikelnr.: 62920839
- Verlag: Elsevier Science & Technology
- Seitenzahl: 468
- Erscheinungstermin: 21. April 2022
- Englisch
- Abmessung: 235mm x 191mm
- Gewicht: 1124g
- ISBN-13: 9780323992831
- ISBN-10: 0323992838
- Artikelnr.: 62920839
1. Clinical and safety assessment of the HCC patients2. Liver
transplantation for HCC therapy3. Clinical trials for HCC in the diagnosis
and therapy: An international perspective4. Recent advancements in
immunotherapy interventions for the management of HCC5. Role of genetic
insights and tumor microenvironment in HCC: New opportunities for gene
therapy6. An Update on the treatment of hepatocellular carcinoma7. An
update of image-based surveillance in HCC8. Meta-analysis of PD-1/PD-L1
inhibitors in advanced HCC9. Towards a personalized medicine approach for
the treatment of HCC10. Precision medicine in the theranostics of HCC11.
Immunohistology of HCC-enabled precision medicine12. Artificial
Intelligence and Precision Medicine for HCC13. Genomics-Enabled Precision
Medicine for HCC
transplantation for HCC therapy3. Clinical trials for HCC in the diagnosis
and therapy: An international perspective4. Recent advancements in
immunotherapy interventions for the management of HCC5. Role of genetic
insights and tumor microenvironment in HCC: New opportunities for gene
therapy6. An Update on the treatment of hepatocellular carcinoma7. An
update of image-based surveillance in HCC8. Meta-analysis of PD-1/PD-L1
inhibitors in advanced HCC9. Towards a personalized medicine approach for
the treatment of HCC10. Precision medicine in the theranostics of HCC11.
Immunohistology of HCC-enabled precision medicine12. Artificial
Intelligence and Precision Medicine for HCC13. Genomics-Enabled Precision
Medicine for HCC
1. Clinical and safety assessment of the HCC patients2. Liver
transplantation for HCC therapy3. Clinical trials for HCC in the diagnosis
and therapy: An international perspective4. Recent advancements in
immunotherapy interventions for the management of HCC5. Role of genetic
insights and tumor microenvironment in HCC: New opportunities for gene
therapy6. An Update on the treatment of hepatocellular carcinoma7. An
update of image-based surveillance in HCC8. Meta-analysis of PD-1/PD-L1
inhibitors in advanced HCC9. Towards a personalized medicine approach for
the treatment of HCC10. Precision medicine in the theranostics of HCC11.
Immunohistology of HCC-enabled precision medicine12. Artificial
Intelligence and Precision Medicine for HCC13. Genomics-Enabled Precision
Medicine for HCC
transplantation for HCC therapy3. Clinical trials for HCC in the diagnosis
and therapy: An international perspective4. Recent advancements in
immunotherapy interventions for the management of HCC5. Role of genetic
insights and tumor microenvironment in HCC: New opportunities for gene
therapy6. An Update on the treatment of hepatocellular carcinoma7. An
update of image-based surveillance in HCC8. Meta-analysis of PD-1/PD-L1
inhibitors in advanced HCC9. Towards a personalized medicine approach for
the treatment of HCC10. Precision medicine in the theranostics of HCC11.
Immunohistology of HCC-enabled precision medicine12. Artificial
Intelligence and Precision Medicine for HCC13. Genomics-Enabled Precision
Medicine for HCC